Supply Chain and Enterprise Risk Management: Navigating the Unknown (Re-engineering the Health Care Supply Chain: A CQO Thought Leader Discussion Series) An AHRMM and ASHRM Joint Presentation

By AHRMM

AHRMM Webinar Image

 

Price: Member: FREE  |  Non-Member: $49.00

CEC Hours: 1

Order Webinar

  

 

Re-engineering the Health Care Supply Chain: A CQO Thought Leader Discussion Series” is hosted by AHRMM's Cost, Quality and Outcomes (CQO) Movement sponsors. This webinar series focuses on how the health care supply chain will evolve and be more resilient in the post-pandemic environment.

As the COVID-19 crisis continues, supply chain and risk management professionals must work closely together to mitigate health care supply chain risks at the global, supplier and product levels.

Join AHRMM and the American Society for Health Care Risk Management (ASHRM), in the fifth and final webinar in AHRMM’s “CQO Thought Leader Discussion Series: Re-engineering the Health Care Supply Chain”. Engage with senior leaders within the finance/supply chain and risk management disciplines who will share their thoughts on the organizational and patient risks related to current vulnerabilities and action planning that health care organizations can take to minimize their exposure to these risks. Key takeaways include ERM frameworks and cost verses risk mitigation strategies.

 

Panelists:

  • Barbara McCarthy, Health Enterprise Risk Officer, Beverly Hospital
  • Mary Beth Briscoe, former CFO and Health Care Supply Chain Executive, AHRMM Board Member
  • Mike Schiller, Senior Director, AHRM

 

Sponsored By:

CQO Sponsors

Related Resources

Supply Chain Strategies & Solutions Article
Supply chain must play an integral role in the care delivery process through cross-departmental partnerships that support evidence-based valu
Advisory
An overview of Fiscal Year (FY) 2015 Hospital Value-Based Purchasing (VBP) Program.
Advisory
The Food and Drug Administration (FDA) UDI system is being phased in over several years.
Toolkits/Methodology
How to write a constructive, information-rich comment that clearly communicates and supports its claims to have an impact on regulatory decision…